A Study of Evorpacept (ALX148) in Patients With Advanced HER2+ Gastric Cancer (ASPEN-06)

Clinical trial NCT05002127 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05002127
Sponsor: ALX Oncology Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Gastric Cancer Gastroesophageal Junction Adenocarcinoma Gastric Adenocarcinoma

Start date: 2022-01-15
Primary completion: 2024-05-24
Enrollment: 127

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.